News
FDA Approves First CAR T-Cell Therapy for rrCLL, rrSLL
- Author:
- Sharon Worcester, MA
For the first time, CAR T-cell therapy for treatment of relapsed/refractory CLL or SLL gets FDA approval.
News
FDA Approves Amivantamab First-line Indication for NSCLC
- Author:
- Sharon Worcester, MA
The FDA also granted traditional approval for use in patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations...
News
FDA Approves First Cellular Therapy for Metastatic Melanoma
- Author:
- Sharon Worcester, MA
Patients with metastatic melanoma have potential new treatment option with approval of T-cell immunotherapy.
News
Does Eliminating Alcohol Intake Lower Cancer Risk?
- Author:
- Sharon Worcester, MA
There is limited evidence to support a link between eliminating or reducing alcohol consumption and lowering of cancer risk.
News
New Guidelines: Start PSA Screening Earlier in Black Men
- Author:
- Sharon Worcester, MA
Baseline PSA testing in Black men should begin at age 40-45, and should be followed by regular screening intervals, preferably annually.
News
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations
- Author:
- Sharon Worcester, MA
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
News
Young Myeloma Specialist Forges Ahead, Gives Back
- Author:
- Sharon Worcester, MA
“Manni” Mohyuddin, MD, reflects on patient needs, compassionate care, medical education, and recent advances in treating multiple myeloma.
News
CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval
- Author:
- Sharon Worcester, MA
Ten weeks ahead of target date, FDA greenlights this innovative treatment for a rare blood disorder.
News
Serum Hormone Concentrations May Predict Aromatase Inhibitor Benefit for BC Prevention
- Author:
- Sharon Worcester, MA
Measuring estradiol, testosterone, and SHBG more widely to identify those postmenopausal women at high risk for breast cancer who would benefit...
News
New Multiple Myeloma Staging Systems Outperform the Standard
- Author:
- Sharon Worcester, MA
Retrospective study shows that the proposed new systems offer more refined risk classifications in stages of myeloma.
News
No Benefit to Salvage Transplant in R/R Multiple Myeloma
- Author:
- Sharon Worcester, MA
Fresh data confirm that a second transplant does not improve survival vs. standard two-drug regimen for relapsed myeloma.
News
MRD status predicts transplant benefit in NPM1-mutated AML
- Author:
- Sharon Worcester, MA
Certain patients with NPM1-mutated acute myeloid leukemia and measurable residual disease were shown to benefit from transplantation.
News
CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases?
- Author:
- Sharon Worcester, MA
New research suggests that CAR T-cell therapy might prove to be a game-changing treatment for lupus and two other autoimmune diseases.
News
FDA greenlights iptacopan to treat paroxysmal nocturnal hemoglobinuria
- Author:
- Sharon Worcester, MA
The first oral monotherapy for a rare chronic blood disorder, paroxysmal nocturnal hemoglobinuria, has been approved by the FDA.
News
How to address chemo-related amenorrhea in early breast cancer to help improve quality of life
- Author:
- Sharon Worcester, MA
Management of premenopausal women with early breast cancer undergoing chemotherapy should include adapted strategies for risk communication,...